Summarized by Masters of Longevity from Lifespan.io.
Regulatory frameworks are delaying multi‑organ translation of aging therapies.
Key Takeaways
- Current rules are forcing separate clinical packages for each organ.
- Validated surrogate and functional endpoints are not widely accepted.
- Policy shifts and international models were reported as emerging solutions.
